REPS1 Activators
REPS1 Activators comprises a group of compounds that can influence the activation or function of REPS1 (Receptor Expression Enhancing Protein 1), a protein involved in the regulation of receptor trafficking and cellular signaling processes. One approach to indirectly activate REPS1 is through the inhibition of phosphoinositide 3-kinase (PI3K) using compounds like Wortmannin. PI3K inhibition alters lipid signaling dynamics, indirectly impacting REPS1-mediated receptor trafficking and signaling events. Another indirect activator is Genistein. Genistein modulates tyrosine kinase activity, which plays a pivotal role in receptor signaling and trafficking processes regulated by REPS1. AdditionallyStaurosporine can indirectly affect REPS1-mediated processes by targeting a range of kinases involved in receptor trafficking and cellular signaling, thus influencing REPS1 function.
Furthermore, Geldanamycin, another activator, targets Hsp90, a molecular chaperone involved in protein folding and trafficking. Through interference with Hsp90 function, geldanamycin indirectly influences receptor folding and trafficking processes regulated by REPS1. Chloroquine, known to affect lysosomal function and trafficking, indirectly impacts receptor trafficking pathways, affecting REPS1-mediated processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a phosphoinositide 3-kinase (PI3K) inhibitor. It indirectly impacts REPS1-mediated receptor trafficking and signaling by altering lipid signaling dynamics. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor. It indirectly influences REPS1 by modulating tyrosine kinase activity, which may play a role in receptor signaling and trafficking processes. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor. It indirectly affects REPS1-regulated processes by targeting various kinases involved in receptor trafficking and cellular signaling. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A inhibits the function of small GTPases like Arf1, involved in vesicular transport and Golgi organization. It indirectly influences receptor trafficking pathways potentially involving REPS1. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore inhibits dynamin, a protein involved in endocytosis and vesicle scission. By interfering with endocytic processes, dynasore indirectly influences receptor trafficking and signaling pathways, potentially affecting REPS1 function. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubule dynamics crucial for intracellular receptor transport. The perturbation of microtubule-based trafficking pathways can indirectly impact REPS1's role in receptor trafficking. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide stabilizes actin filaments, impacting cytoskeletal dynamics. This alteration in actin organization indirectly influences receptor trafficking processes regulated by REPS1. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D disrupts actin polymerization, affecting the organization of the actin cytoskeleton. This indirectly influences receptor transport pathways, potentially impacting REPS1 function. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
2-Deoxyglucose can interfere with glycolytic processes and energy metabolism. Changes in cellular energy availability may indirectly affect receptor trafficking pathways, including those involving REPS1. | ||||||